je.st
news
Citigroup Inc. Initiates Coverage on Teva Pharmaceutical Industries Ltd
2013-10-27 07:18:34| Biotech - Topix.net
The firm set a "buy" rating and a $47.00 price target on the stock. Citigroup Inc.'s price objective suggests a potential upside of 12.71% from the stock's previous close.
Tags: ltd
industries
coverage
pharmaceutical
Category:Biotechnology and Pharmaceuticals